JournalMedabis
Six markets, one conversation
America, Europe, Thailand, Canada, Portugal and the UK see the same flower very differently. Medabis was built in the gap between those views.

Entry
America has decades of product culture and very little patience for mediocre flower. Europe, where The Plug leads, sees supply as a question of moving product well between regulated markets. Thailand is a young market that has moved fast. Canada has shown what compliant production looks like at scale. Portugal is where much of Europe’s cultivation and processing now sits. And the UK is a young medical market still working out what things should cost.
Put those views in one room and something useful happens. One side asks whether the flower is actually good. Another asks what it costs to move it properly. The UK asks what a pharmacy, and ultimately a patient, will be asked to pay.
Medabis came out of that room, and out of long-term friendships that made the room possible. It is why the company names its partners rather than hiding them.